JP Morgan Chase’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
JP Morgan Chase's IONS Position: Q3 2026 in Review
JP Morgan Chase reduced its Ionis Pharmaceuticals (IONS) stake by 63% in Q3 2026, selling an estimated $96.4M and leaving 975,886 shares worth $45.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1528.
JP Morgan Chase first reported a position in IONS in Q2 2013 and has held it in 54 quarters since. The position peaked at $216M in Q2 2026. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- JP Morgan Chase held 975,886 shares of Ionis Pharmaceuticals worth $45.2M as of Q3 2026.
- JP Morgan Chase sold 1,695,831 Ionis Pharmaceuticals shares in Q3 2026, an estimated $96.4M.
- Ionis Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #1528 holding.
- JP Morgan Chase first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 54 quarters since.
- JP Morgan Chase's Ionis Pharmaceuticals position peaked at $216M in Q2 2026.
- 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.